Eagle Pharmaceuticals Inc

NASDAQ:EGRX  
46.62
+0.95 (+2.08%)
Products

Eagle Pharmaceuticals Granted Additional Patent For Bendamustine Franchise

Published: 08/31/2021 11:06 GMT
Eagle Pharmaceuticals Inc (EGRX) - Eagle Pharmaceuticals Granted Additional Patent for Bendamustine Franchise.
Eagle Pharmaceuticals - is Submitting '483 Patent for Listing in U.S. FDA's Orange Book for Both Bendeka and Belrapzo.